The therapeutic role of sulfated polysaccharides in the urinary bladder.
Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. Interstitial cystitis is the first disease explored for the potential use of polysaccharide therapy, which appears to be effective in some patients with this syndrome.